Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BHP Early Infant Treatment Study: A Clinical Treatment Trial of HIV+ Infants in Botswana

NCT02369406 is registered in ClinicalTrials.gov with Harvard School of Public Health (HSPH) as lead sponsor.

NCT NCT02369406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02369406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BHP Early Infant Treatment Study: A Clinical Treatment Trial of HIV+ Infants in Botswana
Lead sponsor
Harvard School of Public Health (HSPH)
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
May 4, 2015
Completion date
June 30, 2029
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, pediatric aids